Loading provider…
Loading provider…
Dermatology Physician in Rockville, MD
NPI: 1275523110Primary Practice Location
Ambulatory Plastic Surgery Center Associates, Chartered
15245 Shady Grove Rd, Rockville, MD
Primary Employer
Derm Associates LLC
usdermatologypartners.com
HQ Phone
Get MD Benjamin's Phone Numberphone_androidMobile
Get MD Benjamin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
OH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 994 | 1,324 |
| 2 | 17000Destruction of skin growth | 710 | 911 |
| 3 | 17003Destruction of 2-14 skin growths | 491 | 2,214 |
| 4 | 11102Tangential biopsy of single skin lesion | 435 | 479 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 352 | 472 |
A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab.
Authors: Andrew Blauvelt
Publication Date: 2022-03
Authors: Neal Bhatia, Janet Dubois, Neal Bhatia, David Chu, Michael Bukhalo, Javier Alonso-Llamazares, Patrick Burnett, Leon Kircik
Journal: JAMA Dermatol
Publication Date: 2025-05-07
Authors: Neal Bhatia, Tina Bhutani-Jacques, Ethan Levin, Neal Bhatia, Kristen Beck, John Koo
Journal: J Drugs Dermatol
Lead Sponsor: Incyte Corporation
Intervention / Treatment: DRUG: Vehicle Cream, DRUG: Ruxolitinib Cream
Lead Sponsor: University of Pennsylvania
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Celgene Corporation
Intervention / Treatment: DRUG: Apremilast
Lead Sponsor: Eli Lilly and Company
Collaborators: Dermira, Inc.
Intervention / Treatment: BIOLOGICAL: Lebrikizumab